Leveraging Microbiota Transplant Therapy to Modulate the Gut-Brain Axis

12:15 pm - Wednesday 11th November 2026

  • Explaining the contribution of gut microbiota to neurologic symptoms
  • Use a pharmacological framework in the development of fecal microbiota live biotherapeutic products
  • Present clinical evidence of durable therapeutic benefits of targeting the gut microbiome with microbiota transplant therapy

Speakers:

Chief Medical Officer
Gut-Brain Axis Therapeutics